Auxilium seeks to in-partner products that treat serious problems that affect men and women as they age. Auxilium will consider various partnership arrangements such as: licensing, acquisition, and promotion. The company prefers marketed products or late-stage therapeutic candidates, but will consider earlier stage opportunities for differentiated molecules/products.

Indications of interest include:

• Benign prostatic hyperplasia
• Bladder cancer
• Erectile dysfunction
• Female sexual dysfunction
• Hypogonadism (TRT)
• Interstitial cystitis
• Male contraception
• Pain products
• Penile cancer
• Peyronie’s disease
• Premature ejaculation
• Prostate cancer
• Urinary antispasmodics
• Urinary incontinence / overactive bladder
• Urinary tract infections
• Other urologic or genitourinary abnormalities
• Endocrine-related disease states